Gyre Therapeutics
Price & Volume
Stats
See more52W Range | $6.11-$19 |
Market Cap | $739.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $102.1M |
Revenue Growth (YoY) | 6.1% |
Gross Profit (12 Mos) | $98M |
Diluted EPS | $0.02 |
News
See moreYahoo Finance • 7 days ago
Gyre Therapeutics Reports Second Quarter 2025 and Year-to-Date Financial Results and Provides Business and Leadership Update
Yahoo Finance • 2 months ago
Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China
Yahoo Finance • 3 months ago
Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Yahoo Finance • 3 months ago
Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock
About
CEO | Mr. Ping Zhang |
Address | 12770 High Bluff Drive, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 579 |
